JDD Webinars

Differentiating Approach to Acne Therapy: Women Vs. Men

By October 14, 2020April 22nd, 2021No Comments

Featured Article

Differentiating Approach to Acne Therapy: Women vs. Men

Join Drs. Leon H. Kircik, MD and Julie Harper, MD as they discuss Acne severity and grade (comedonal, papulopustular, mixed, nodular), skin type, presence of acne scarring and postinflammatory hyperpigmentation, menstrual cycle history (in women), and more, as well as the factors influencing treatment with classes of topical agents.

Acne vulgaris is a chronic inflammatory dermatologic disease affecting an estimated 80% of the population at some point in their life; 85% of adolescents and young adult s may experience acne and prevalent in adults with more adult women being afflicted than adult men, raising the possibility that gender difference in skin may influence the pathogenesis of acne and treatment response.
Dermatologists indicate late-onset or adult -onset acne is becoming increasingly common in women in their 20s to 50s and research shows a large number of women over age 25 have acne and the prevalence of acne remains constant until age 44 at which time there is a decrease in incidence.

FACULTY


Leon H. Kircik, MD
Clinical Professor of Dermatology
Indiana University School of Medicine
Mount Sinai Medical Center, New York, NY
Physicians Skin Care, PLLC
Louisville, KY


Julie C. Harper, MD
Clinical Associate Professor of Dermatology
University of Alabama-Birmingham
Birmingham, Alabama

Watch Now

You May Also Like

Moringa-Derived Formulations for Hair Growth, Hair Preservation, and Hair Loss: A Systematic Review

| Alopecia, Featured Articles, Hair, Latest News | No Comments
Exploring the Potential of Moringa Formulations in Hair Health and Alopecia Management  Have you read this compelling new systematic review from the Journal of Drugs in Dermatology. As hair loss,…

JDD Re:View With Dr. Beer

| Featured Articles, JDD Re:View, Latest News, Skin of Color | No Comments
Skin of Color: Bridging the Knowledge Gap As the patient population becomes more diverse in the United States, it is becoming increasingly important for dermatologists to be comfortable counseling patients…

La Roche-Posay: Intercepting Melanin Precursors for Next-Generation Dark Spot Correction

| Featured Articles, The Latest, Webinars on Demand | No Comments
Join Janiene Luke, MD, to discover how MELAB3’s breakthrough active, Melasyl (2 MNG), intercepts melanin precursors before they form dark spots, setting a new standard for safety and efficacy across…

Leave a Reply